Fatma Özdemir

Dr. Fatma Özdemir

ICU, Bakırköy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, İstanbul, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
DBDicle Birtane
Dicle Birtane
Fatma ÖzdemirFatma Özdemir
Fatma Özdemir
DYDamla Yavuz
Damla Yavuz
ZCZafer Cukurova
Zafer Cukurova
Background: In critically ill patients, tracheostomy decisions are driven by heterogeneous and dynamic clinical trajectories, and no universally accepted scoring system exists to reliably predict tracheostomy requirement. An accurate and interpretable prediction model could help earlier decision-making and potentially reduce prolonged mechanical ventilation (MV) and failed weaning. Methods: In this retrospective study, data from 6507 mechanically ventilated intensive care unit (ICU) patients were analyzed using an electronic clinical decision support system; 1049 patients required tracheostomy and 5458 did not. The primary outcome was the prediction of tracheostomy occurrence during ICU stay based on invasive mechanical ventilation (IMV) parameters obtained within the first five days. The secondary outcome was the identification of the most influential parameters guiding tracheostomy decision-making during early IMV. Ten machine learning algorithms were developed using an 80/20 train–test split. Model performance was assessed using discrimination, calibration, and clinical performance metrics. Explainability was evaluated using SHapley Additive exPlanations (SHAP) analysis. Results: Among all models, Gradient Boosting demonstrated strong discrimination and calibration performance (AUROC 0.92, AUPRC 0.56, specificity 97%, F1 score 0.46, Brier score 0.078). In the Gradient Boosting model, feature importance analysis demonstrated that secretion count was the strongest predictor of tracheostomy requirement, accounting for 14.72% of the model’s predictive contribution. This was followed by lactate level (6.12%), arterial pH (3.74%), and peak airway pressure (3.57%). SHAP-based analyses consistently identified secretion count as the strongest predictor of tracheostomy requirement, followed by lactate level, Glasgow Coma Scale (GCS), and arterial pH. In addition, SHAP provided clinically interpretable insights into the direction and magnitude of the effects of individual predictors. Conclusions: Machine learning models integrating early-phase ventilatory and physiological data may enable clinically meaningful prediction of tracheostomy requirement. The combination of strong performance and explainability suggests potential utility as a decision-support tool in critically ill patients requiring prolonged MV.

1 January 2022 in Acta Clinica Croatica
Verified
Journal Article
Open access
PDF file
Fatma ÖzdemirFatma Özdemir
Fatma Özdemir
AŞAyça Sultan Şahin
Ayça Sultan Şahin
Ziya SalihogluZiya Salihoglu
Ziya Salihoglu
Transversus abdominis plane (TAP) block is used to provide analgesia after lower abdominal surgery operations. TAP block has been shown to reduce postoperative pain scores and side effects of opioids after cesarean section. Generally, TAP block was...

14 February 2026 in Medicina
Verified
Journal Article
Open access
PDF file
Fatma ÖzdemirFatma Özdemir
Fatma Özdemir
DBDicle Birtane
Dicle Birtane
NYNURDAN YILMAZ
NURDAN YILMAZ
ZCZafer Cukurova
Zafer Cukurova
Background and Objectives: Neuroleptic malignant syndrome (NMS) is a rare but high-mortality clinical condition. The aim of this study was to describe the demographic characteristics, clinical and laboratory findings, management strategies, and clinical outcomes of adult patients with NMS treated in an adult intensive care unit. Materials and Methods: This retrospective descriptive study included adult patients admitted to a tertiary care ICU with a diagnosis of NMS. Data were obtained from medical records and included demographic characteristics, suspected NMS-related drug exposures, clinical and laboratory findings at ICU admission, disease severity indicators, treatments administered, and clinical outcomes. Continuous variables were expressed as median and interquartile range (IQR), and categorical variables as number and percentage. Results: A total of 42 patients were included. The median age was 48 years (IQR: 24.1–75.5), and 61.9% were male. Atypical antipsychotics were the most frequently implicated agents (69.0%). Altered mental status was observed in 92.9% of patients, tachycardia in 61.9%, and hyperthermia in 47.6%. Creatine kinase levels >1000 U/L were present in 57.1%, and leukocytosis in 71.4%. Mechanical ventilation was required in 59.5% of patients. Acute kidney injury developed in 31%, and continuous renal replacement therapy (CRRT) was initiated in 21.4%. Bromocriptine was administered in 54.8% of cases, dantrolene in 4.8%, and amantadine in 11.9%. The ICU mortality rate was 9.5%. Conclusions: Patients with neuroleptic malignant syndrome often present with a severe clinical course requiring advanced organ support in the intensive care unit. However, with early diagnosis and appropriate intensive care management, mortality can be maintained at acceptable levels.

28 September 2021 in Medical Journal of Bakırkoy
Verified
Journal Article
Closed access
MSMehmet Süleyman Sabaz
Mehmet Süleyman Sabaz
Fatma ÖzdemirFatma Özdemir
Fatma Özdemir
OÖOğuz Özakın
Oğuz Özakın
ÜTÜlkü Aygen Türkmen
Ülkü Aygen Türkmen
VDVeysel DİNÇ
Veysel DİNÇ

21 June 2026 in Turkish Journal of Intensive Care
Verified
Journal Article
Open access
PDF file
Fatma ÖzdemirFatma Özdemir
Fatma Özdemir
DBDicle Birtane
Dicle Birtane
ZCZafer Cukurova
Zafer Cukurova
Objective: This case series aims to present the clinical characteristics, diagnostic processes, treatment strategies, and outcomes of patients with methanol intoxication treated in the intensive care unit (ICU). Methods: Eight male patients, aged between 31 and 75 years, who were treated in the ICU for methanol intoxication within three weeks, were included. Their medical histories, clinical findings, laboratory results, treatments, and prognoses were described. Results: The patients presented with a variety of symptoms such as visual loss, nausea, vomiting, abdominal pain, altered mental status, and respiratory distress. All patients had a history of consuming homemade alcohol, although in some cases the exact source and amount of alcohol were unknown. Arterial blood gas analyses revealed metabolic acidosis with elevated lactate levels. Negative blood ethanol levels, along with increased anion and osmolar gaps, supported the diagnosis of methanol intoxication. Patients received intravenous ethanol infusion, hemodialysis, and appropriate ICU supportive treatments. Three patients died (37.5%), while five survived. Conclusion: This case series emphasizes the importance of prompt intervention in emergencies such as methanol intoxication. Early diagnosis and administering antidotes like ethanol and hemodialysis improve survival rates. Preventing the production of counterfeit alcohol and raising public awareness of its dangers should be key priorities.

25 September 2026 in Medicine
Verified
Journal Article
Open access
DBDicle Birtane
Dicle Birtane
DDDamla Özmen Dönmezler
Damla Özmen Dönmezler
Fatma ÖzdemirFatma Özdemir
Fatma Özdemir
ZCZafer Cukurova
Zafer Cukurova
Sepsis involves dynamic inflammatory and endothelial responses, and the timing of extracorporeal therapies such as therapeutic plasma exchange (TPE) may influence clinical outcomes. However, the optimal timing of TPE remains unclear. This retrospective single-center observational study included adult patients with sepsis or septic shock who underwent TPE in the intensive care unit between January 1, 2017 and August 1, 2025. Patients were categorized as early (≤ 48 hours after diagnosis) or late (> 48 hours). The primary outcome was 28-day mortality. Secondary analyses evaluated longitudinal changes in biomarkers and laboratory parameters. Eighty-eight patients were included (early n = 39; late n = 49). Overall 28-day mortality was 40.9% (36/88). Kaplan–Meier analysis demonstrated no significant difference in 28-day survival between the groups (log-rank P = .91). In multivariable Cox regression adjusted for Sequential Organ Failure Assessment and Acute Physiology and Chronic Health Evaluation II, TPE timing was not independently associated with 28-day mortality (hazard ratio 0.90, 95% confidence interval 0.44–1.83, P = .76). Across the overall cohort, significant temporal changes were observed in C-reactive protein and lactate dehydrogenase levels during TPE treatment. Early TPE initiation was not associated with improved 28-day survival. Observed biomarker trajectories should be interpreted cautiously given the retrospective design, limited sample size, and potential residual confounding.